Noonan Spectrum Disorders/Rasopathies NGS panel
|A2ML1, ACTB, ACTG1, BRAF, CBL, HRAS, KAT6B, KRAS, LZTR1, MAP2K1, MAP2K2, MRAS, NF1, NRAS, PPP1CB, PTPN11, RAF1, RASA1, RASA2, RIT1, RRAS, SHOC2, SOS1, SOS2, SPRED1|
|Lab method:||NGS panel
NGS panel with CNV
|Specimen requirements:||2-4 ml of blood with anticoagulant EDTA
1 µg DNA in TE, AE or pure sterile water at 100-250 ng/µl
|Ordering information:||Go to online ordering or download sample submission form|
Indications for genetic testing:
- Confirmation of clinical diagnosis
- Parental testing in case of a causative mutation has been identified in an affected individual
- Genetic counseling
- Prenatal diagnosis
Noonan syndrome is an autosomal dominantly inherited disease characterized by short stature, congenital heart defect and delayed mental development of varying degree. Patients with Noonan syndrome also have a characteristic appearance: short neck, cervical skin fold, low set ears, hypertelorism. Additionally lymphatic system dysplasia may occur, which is the basis of cystic hygroma and occipital fold enlargement in the fetus.
The incidence of Noonan syndrome is about 1:1000-2500. Noonan syndrome is genetically heterogeneous. In 50% of patients mutations occur in the PTPN11 gene. 10% of cases are associated with mutations in the SOS1 gene, 3% in the RAF1 gene and 1% in the KRAS gene.